Skip to main content
OpenTrials
Not Yet Recruiting

NCT Number: NCT07596953

Efficacy of TECAR Therapy on Patient With Mechanical Neck Pain

The goal of this clinical trial is to evaluate the effectiveness of TECAR therapy in improving pain intensity, cervical range of motion, and functional disability in individuals with mechanical neck pain. It will also assess whether TECAR therapy provides additional clinical benefits compared with conventional physical therapy treatment. The main questions it aims to answer are:

* Does TECAR therapy reduce pain intensity in patients with mechanical neck pain? * Does TECAR therapy improve cervical range of motion (CROM)? * Does TECAR therapy reduce functional disability as measured by the Neck Disability Index (NDI)? Researchers will compare participants receiving TECAR therapy combined with conventional physical therapy to participants receiving conventional physical therapy alone to determine the effectiveness of TECAR therapy in managing mechanical neck pain.

Participants will:

* Attend scheduled treatment sessions during the study period * Receive either TECAR therapy with conventional physical therapy or conventional physical therapy alone * Undergo assessment of pain intensity, cervical range of motion, and neck disability before and after treatment

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

MECHANICAL BACK PAIN

Age range

20 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Saudi German Hospital

Jeddah, Al Zahraa, 23623, Saudi Arabia

About this study

Mechanical neck pain is one of the most common musculoskeletal disorders and is frequently associated with pain, restricted cervical mobility, and reduced functional performance, which may negatively affect daily activities and quality of life. Conventional physical therapy interventions are commonly used to manage mechanical neck pain; however, interest has recently increased in the use of TECAR therapy as a non-invasive modality that may enhance tissue healing, improve circulation, reduce pain, and restore function.

This single-blind randomized controlled trial aims to investigate the clinical effectiveness of TECAR therapy in individuals with mechanical neck pain. Participants who meet the eligibility criteria will be randomly assigned to either an experimental group receiving TECAR therapy in combination with conventional physical therapy or a control group receiving conventional physical therapy alone.

Outcome measures will be assessed before and after the intervention period and will include pain intensity, cervical range of motion (CROM), and functional disability using the Neck Disability Index (NDI). The study seeks to determine whether adding TECAR therapy to a conventional rehabilitation program provides superior improvements in pain reduction, cervical mobility, and functional outcomes in patients with mechanical neck pain.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Presence of neck pain for at least 3 months
  • Limited cervical range of motion associated with neck pain
  • Ability to understand and follow study instructions Willingness to participate and sign the informed consent form

Exclusion criteria

  • History of cervical spine surgery or fracture
  • Cervical radiculopathy or other neurological disorders
  • Presence of inflammatory, rheumatic, or systemic diseases affecting the cervical spine

Severe cervical disc prolapse or spinal instability Current participation in another treatment program for neck pain Pregnancy Presence of pacemakers, metal implants, or contraindications to TECAR therapy Skin disorders or open wounds in the treatment area

Treatment and study plan

TECAR

Device

Participants in the TECAR group received TECAR therapy in capacitive and resistive modes targeting superficial and deep tissues of the affected area. Each session lasted 20-30 minutes, with intensity adjusted to produce a comfortable thermal effect without pain. TECAR therapy was applied three times/week for 12 weeks, alongside a standardized exercise program identical to the control group.

Conventional

Other

Participants in the control group received a standardized therapeutic exercise program. The program included stretching, strengthening, and functional exercises targeting the affected region. Each session lasted 20-30 minutes and was performed three times/week for 12 weeks.

Primary outcomes

  1. Pain Intensity

    Time frame: Assessments will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)

    Pain intensity was measured using the Visual Analog Scale (VAS) to assess changes in neck pain intensity throughout the study period. The VAS is a self-reported pain assessment tool consisting of a 10-cm horizontal line, with scores ranging from 0 to 10, where 0 indicates "no pain" and 10 indicates "worst imaginable pain." Higher scores represent greater pain intensity and therefore a worse outcome.

Secondary outcomes

  1. Cervical Range of Motion (CROM)

    Time frame: Baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)

    Measured using a Cervical Range of Motion device to evaluate changes in cervical flexion, extension, lateral flexion, and rotation.

  2. Functional Disability

    Time frame: Assessment will be conducted at baseline (pre-treatment), immediately post-intervention (after 12 sessions), and follow-up (1 month after completion)

    Functional disability was measured using the Neck Disability Index (NDI) to assess changes in functional limitations associated with mechanical neck pain. The NDI is a self-administered questionnaire consisting of 10 items related to daily activities and pain. Each item is scored from 0 to 5, with a total score ranging from 0 to 50, where 0 indicates no disability and 50 indicates complete disability. Higher scores represent greater functional disability and therefore a worse outcome.

Study contacts

Contact information is provided by the study sponsor or research team.

Mohamed A Abdel Ghafar, Ph.D.

CONTACT

[email protected]

00966531513909

Sponsors and collaborators

Lead sponsor

Batterjee Medical College

Other

Collaborators

  • Saudi German Hospital

Registry information

Official study title

Influence of TECAR Therapy on Cervical Mobility and Functional Disability in Patients With Mechanical Neck Pain: Randomized Control Study

Important dates

Study start
2026
Primary completion
2026
Study completion
2026
First posted
May 19, 2026
Registry last updated
May 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.